African Union's health agency vows Ebola Bundibugyo vaccine by end of 2026
The Africa CDC has announced plans to develop a vaccine for the Bundibugyo strain of Ebola by the end of 2026. This strain has caused significant outbreaks in the Democratic Republic of Congo, and currently lacks an approved vaccine or treatment. The agency is collaborating with various stakeholders to ensure the vaccine's development and distribution.
- ▪The Bundibugyo strain of Ebola currently has no approved vaccine or treatment.
- ▪Africa CDC aims to have a vaccine ready by the end of 2026.
- ▪There have been at least 1,077 suspected cases of Ebola since the outbreak was declared on May 15, 2026.
Opening excerpt (first ~120 words) tap to expand
A vaccine against the Bundibugyo strain of the Ebola virus will be ready by the end of the year, the Director General of Africa Centres for Disease Control and Prevention (Africa CDC) said on Thursday (May 28, 2026).The Bundibugyo strain of the virus that has caused a major outbreak in the Democratic Republic of Congo currently has no approved vaccine or treatment. India sends emergency medical supplies for Ebola outbreak response in CongoJean Kaseya, head of Africa CDC, said there were already "some candidates" for a vaccine."What we can tell you for sure, by the end of this year, 2026, Africa CDC will make sure that we have a vaccine and medicine against Bundibugyo," he told reporters in an online briefing."Our leaders are ready to invest.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu — Top.
Discussion
0 commentsMore from The Hindu — Top
